246 related articles for article (PubMed ID: 9249603)
1. Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome.
Smoyer WE; Mundel P; Gupta A; Welsh MJ
Am J Physiol; 1997 Jul; 273(1 Pt 2):F150-7. PubMed ID: 9249603
[TBL] [Abstract][Full Text] [Related]
2. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin.
Reiser J; Oh J; Shirato I; Asanuma K; Hug A; Mundel TM; Honey K; Ishidoh K; Kominami E; Kreidberg JA; Tomino Y; Mundel P
J Biol Chem; 2004 Aug; 279(33):34827-32. PubMed ID: 15197181
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between podocyte molecule's distribution and expression, foot process morphology and proteinuria].
Guan N; Deng JH; Ding J; Zhang JJ; Yang JY
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):139-44. PubMed ID: 15100730
[TBL] [Abstract][Full Text] [Related]
4. Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat.
Luimula P; Sandström N; Novikov D; Holthöfer H
Lab Invest; 2002 Jun; 82(6):713-8. PubMed ID: 12065681
[TBL] [Abstract][Full Text] [Related]
5. Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside.
Vega-Warner V; Ransom RF; Vincent AM; Brosius FC; Smoyer WE
Kidney Int; 2004 Nov; 66(5):1881-9. PubMed ID: 15496159
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of PPARγ agonist in acute nephrotic syndrome.
Zuo Y; Yang HC; Potthoff SA; Najafian B; Kon V; Ma LJ; Fogo AB
Nephrol Dial Transplant; 2012 Jan; 27(1):174-81. PubMed ID: 21565943
[TBL] [Abstract][Full Text] [Related]
7. Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis.
Dunér F; Lindström K; Hultenby K; Hulkko J; Patrakka J; Tryggvason K; Haraldsson B; Wernerson A; Pettersson E
Nephron Exp Nephrol; 2010; 116(2):e42-52. PubMed ID: 20588063
[TBL] [Abstract][Full Text] [Related]
8. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance.
Tian X; Kim JJ; Monkley SM; Gotoh N; Nandez R; Soda K; Inoue K; Balkin DM; Hassan H; Son SH; Lee Y; Moeckel G; Calderwood DA; Holzman LB; Critchley DR; Zent R; Reiser J; Ishibe S
J Clin Invest; 2014 Mar; 124(3):1098-113. PubMed ID: 24531545
[TBL] [Abstract][Full Text] [Related]
9. Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.
Oh J; Reiser J; Mundel P
Pediatr Nephrol; 2004 Feb; 19(2):130-7. PubMed ID: 14673634
[TBL] [Abstract][Full Text] [Related]
10. Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis.
Shirato I; Sakai T; Kimura K; Tomino Y; Kriz W
Am J Pathol; 1996 Apr; 148(4):1283-96. PubMed ID: 8644869
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of glomerular heat shock protein 27 in experimental nephrotic syndrome.
Smoyer WE; Gupta A; Mundel P; Ballew JD; Welsh MJ
J Clin Invest; 1996 Jun; 97(12):2697-704. PubMed ID: 8675679
[TBL] [Abstract][Full Text] [Related]
12. Decreased Podocyte Vesicle Transcytosis and Albuminuria in
Hatakeyama S; Tojo A; Satonaka H; Yamada NO; Senda T; Ishimitsu T
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948207
[TBL] [Abstract][Full Text] [Related]
13. Expression of alpha-actinin-4 in acquired human nephrotic syndrome: a quantitative immunoelectron microscopy study.
Goode NP; Shires M; Khan TN; Mooney AF
Nephrol Dial Transplant; 2004 Apr; 19(4):844-51. PubMed ID: 15031339
[TBL] [Abstract][Full Text] [Related]
14. Podocyte foot process effacement in very early phase of passive Heymann nephritis is not a prerequisite for proteinuria.
Nosaka H; Tamura Y; Kojima K; Uchida S; Nagase M
J Nephrol; 2009; 22(4):484-90. PubMed ID: 19662603
[TBL] [Abstract][Full Text] [Related]
15. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
[TBL] [Abstract][Full Text] [Related]
16. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cytoskeletal organization of podocytes during the course of aminonucleoside nephrosis in rats.
Kubosawa H; Kondo Y
Pathol Int; 1994 Aug; 44(8):578-86. PubMed ID: 7952147
[TBL] [Abstract][Full Text] [Related]
18. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.
Eto N; Wada T; Inagi R; Takano H; Shimizu A; Kato H; Kurihara H; Kawachi H; Shankland SJ; Fujita T; Nangaku M
Kidney Int; 2007 Aug; 72(4):455-63. PubMed ID: 17457371
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
Inokuchi S; Shirato I; Kobayashi N; Koide H; Tomino Y; Sakai T
Kidney Int; 1996 Oct; 50(4):1278-87. PubMed ID: 8887289
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
